[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [HEALTH]

2 clusters · 2 sources · 17 days · First seen · Last updated

BPC-157 peptide research and regulatory status

Overview

BPC-157 is a synthetic peptide derived from a protein found in gastric juice that has become a subject of interest in medical research and biohacking communities. Research suggests the compound may support the regeneration of muscles, tendons, ligaments, bones, and neurons by stimulating angiogenic activity and collagen production, while also potentially aiding digestive health.

Despite its regenerative potential, BPC-157 remains an unapproved substance for human use by major regulatory bodies such as the FDA, the European Medicines Agency, and Health Canada. Consequently, the World Anti-Doping Agency (WADA) and the U.S. Anti-Doping Agency prohibit its use by competitive athletes. Experts advise that any potential use requires medical oversight to manage side effects like dizziness, headaches, or injection site reactions.

Entities

European Medicines Agency · BPC-157 · BPC-157 · U.S. Anti-Doping Agency · FDA

Timeline

  1. 17 days ago

    [HEALTH] 2 sources
    BPC-157 peptide researched for tissue regeneration and recovery

    BPC-157 is a synthetic peptide studied for its ability to promote tissue regeneration in muscles, joints, and the digestive system by stimulating blood vessel formation and collagen production.

  2. about 1 month ago

    [HEALTH] 2 sources
    BPC-157 peptide research and regulatory status

    BPC-157 is a research peptide derived from gastric juice. It is not approved for human use by the FDA or EMA and is banned by WADA for competitive athletes.

Sources

fashionsizzle.com · perupesquero.org